Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paliperidone ER for acute agitation or aggression in psychosis
2009-015629-35Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of paliperidone in schizophrenia and Schizophrenia Spectrum Disorders (SSD), sponsored by Janssen Pharmaceutical. Primary endpoint: Primary efficacy endpoint. Started Sep 2009; status: completed.
02
Drugs
paliperidone
03
Conditions
schizophreniaSchizophrenia Spectrum Disorders (SSD)
Beyond the preview
Go deeper on 2009-015629-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015629-35.